Evidence map›Paper›PMID 29017524›Full record

ArticleBMC pulmonary medicine2017

Chronic obstructive pulmonary disease, bronchial asthma and allergic rhinitis in the adult population within the commonwealth of independent states: rationale and design of the CORE study.

Yuriy Feshchenko, Liudmyla Iashyna, Damilya Nugmanova, Olga Gyrina, Maryna Polianska, Alexander Markov, Maryna Moibenko, Janina Makarova, Luqman Tariq, Marcelo Horacio S Pereira and 3 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in BMC pulmonary medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Prevalence and Economic Burden of Respiratory Diseases in Central Asia and Russia: A Systematic Review.International journal of environmental research and public health · 2020
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 4 countries.

Yuriy FeshchenkoNational Institute of Phthisiology and Pulmonology F.G. Yanovsky of NAMS, Kiev, Ukraine.
Liudmyla IashynaNational Institute of Phthisiology and Pulmonology F.G. Yanovsky of NAMS, Kiev, Ukraine.
Damilya NugmanovaSemey State Medical University, Almaty, Kazakhstan.
Olga GyrinaNational Medical University n.a. O.O. Bogomolets, Kiev, Ukraine.
Maryna PolianskaNational Institute of Phthisiology and Pulmonology F.G. Yanovsky of NAMS, Kiev, Ukraine.
Alexander MarkovGlaxoSmithKline, Kiev, Ukraine.
Maryna MoibenkoGlaxoSmithKline, Kiev, Ukraine.
Janina MakarovaGlaxoSmithKline, GSK Russia, Business Park "Krylatsky Hills", 17, Krylatskaya Street, Building 3 ("Air"), 121614, Moscow, Russia. yana.j.makarova@gsk.com.
Luqman TariqGlaxoSmithKline, Dubai, UAE.
Marcelo Horacio S PereiraDepartment of Internal Medicine, State University of Rio de Janeiro (UERJ), Rio de Janeiro, Brazil.
Eljan MammadbayovScientific Research Institute of Lung Diseases, Baku, Azerbaijan.
Irada AkhundovaScientific Research Institute of Lung Diseases, Baku, Azerbaijan.
Averyan VasylyevGlaxoSmithKline, Kiev, Ukraine.
Bogomolets National Medical University · UAGlaxoSmithKline (India) · INSemey Medical University · KZUniversidade do Estado do Rio de Janeiro · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMain treatable Chronic Respiratory Diseases (CRDs) like Chronic Obstructive Pulmonary Disease (COPD), Bronchial Asthma (BA) and Allergic Rhinitis (AR) are underdiagnosed and undertreated worldwide. CORE study was aimed to assess the point prevalence of COPD, BA and AR in the adult population of major cities of Commonwealth of Independent States (CIS) countries - Azerbaijan, Kazakhstan, and Ukraine based on study questionnaires and/or spirometry, and to document risk factors, characterize the COPD, BA and AR population to provide a clearer "epidemiological data".

methodsA descriptive, cross-sectional, population-based epidemiological study conducted from 2013 to 2015 with two-stage cluster geographical randomization. Interviewers conducted face-to-face visits at respondent's household after informed consent and eligibility assessment including interviews, anthropometry, spirometry (with bronchodilator test) and completion of disease-specific questionnaires.

resultsTwo thousand eight hundred forty-two respondents (Ukraine: 964 from Ukraine; 945 from Kazakhstan; 933 Azerbaijan) were enrolled. Mean age was 40-42 years and males were 37%-42% across three countries. In Kazakhstan 62.8% were Asians, but in Ukraine and in Azerbaijan 99.7% and 100.0%, respectively, were Caucasians. Manual labourers constituted 40.5% in Ukraine, 22.8% in Kazakhstan and 22.0% in Azerbaijan, while office workers were 16.1%, 31.6% and 36.8% respectively. 51.3% respondents in Ukraine, 64.9% in Kazakhstan and 69.7% in Azerbaijan were married.

conclusionCORE study collected information that can be supportive for health policy decision makers in allocating healthcare resources in order to improve diagnosis and management of CRDs. The detailed findings will be described in future publications.

trial registrationStudy Protocol Summary is disclosed at GlaxoSmithKline Clinical Study Register on Jun 06, 2013, study ID 116757 .

Indexed as

AdultAsthmaAzerbaijanCross-Sectional StudiesFemaleHumansKazakhstanMaleMiddle AgedPrevalencePulmonary Disease, Chronic ObstructiveRhinitis, AllergicRisk FactorsSpirometrySurveys and QuestionnairesUkraineAllergic rhinitisAzerbaijanBronchial asthmaChronic respiratory diseasesCOPDKazakhstanPrevalenceRisk factorsStudy designUkraine

Identifiers

PMID29017524
PMCPMC5634889
OpenAlexW2761313519

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.